This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Parkinson's Disease

Post describing how you can contribute (Video and Excel data entry)

This is a citizen science site -- you can contribute by investing and sharing your time.

Common knowledge amoung some professionals (MD and ND):

  1. Coenzyme Q10 (CoQ10): Coenzyme Q10 is an antioxidant that plays a role in cellular energy production. Some studies suggest that CoQ10 might have potential benefits in reducing symptoms and slowing the progression of Parkinson's disease. However, more research is needed to establish its effectiveness and appropriate dosages.

  2. Omega-3 Fatty Acids: Omega-3 fatty acids found in fish oil might have anti-inflammatory properties and potential neuroprotective effects. While evidence specific to Parkinson's disease is limited, they might contribute to overall health and potentially support brain health.

  3. Vitamin D: Some research suggests a potential link between low vitamin D levels and Parkinson's disease. Adequate vitamin D levels are important for overall health and might play a role in supporting neurological function, but more research is needed to determine its specific impact on Parkinson's disease.

  4. Probiotics: While not directly related to Parkinson's disease, some studies suggest a potential link between gut health and neurological conditions. Probiotics might influence the gut microbiome and indirectly impact overall health. However, their specific effects on Parkinson's disease require further research.


Bacteria/Taxa

The Studies below identify bacteria. Check if it has already been reviewed.

1 πŸ“š
[Features of gut microbiota in patients with idiopathic Parkinson`s disease].
Zhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi ) Vol: 100 Issue: 13 Pages: 1017-1022 Pub: 2020 Apr 7 ePub: Authors Li Y,Li RX,Du YT,Xu XJ,Xue Y,Gao D,Gao T,Sheng Z,Zhang LY,Tuo HZ
2 πŸ“š
[Frequency of Bordetella pertussis antibodies in serum of patients with Parkinson's disease].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego (Pol Merkur Lekarski ) Vol: 13 Issue: 75 Pages: 185-7 Pub: 2002 Sep ePub: Authors Fiszer U,Tomik B,Krygowska-Wajs A,Michalowska M,Palasik W
3 πŸ“š
[Helicobacter pylori infection and its influence on Parkinson disease].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego (Pol Merkur Lekarski ) Vol: 15 Issue: 89 Pages: 428-31 Pub: 2003 Nov ePub: Authors Wlodarek D,Pakszys W,Bujko J
4 πŸ“š
Desulfovibrio Bacteria Are Associated With Parkinson`s Disease.
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 11 Issue: Pages: 652617 Pub: 2021 ePub: 2021 May 3 Authors Murros KE,Huynh VA,Takala TM,Saris PEJ
5 πŸ“š
Alteration of the fecal microbiota in Chinese patients with Parkinson's disease.
Brain, behavior, and immunity (Brain Behav Immun ) Vol: 70 Issue: Pages: 194-202 Pub: 2018 May ePub: 2018 Mar 2 Authors Qian Y,Yang X,Xu S,Wu C,Song Y,Qin N,Chen SD,Xiao Q
6 πŸ“š
Altered gut microbiota in Parkinson`s disease patients/healthy spouses and its association with clinical features.
Parkinsonism & related disorders (Parkinsonism Relat Disord ) Vol: 81 Issue: Pages: 84-88 Pub: 2020 Dec ePub: 2020 Oct 20 Authors Zhang F,Yue L,Fang X,Wang G,Li C,Sun X,Jia X,Yang J,Song J,Zhang Y,Guo C,Ma G,Sang M,Chen F,Wang P
7 πŸ“š
Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study.
Acta neurologica Belgica (Acta Neurol Belg ) Vol: 123 Issue: 3 Pages: 999-1009 Pub: 2023 Jun ePub: 2023 Jan 31 Authors Babacan Yildiz G,Kayacan ZC,Karacan I,Sumbul B,Elibol B,Gelisin O,Akgul O
8 πŸ“š
Anaerobes in specific infectious and noninfectious diseases: new developments.
Anaerobe (Anaerobe ) Vol: 81 Issue: Pages: 102714 Pub: 2023 Jun ePub: Authors Boyanova L,Markovska R,Yordanov D,Gergova R,Hadzhiyski P
9 πŸ“š
Analysis of Gut Microbiota in Patients with Parkinson's Disease.
Bulletin of experimental biology and medicine (Bull Exp Biol Med ) Vol: 162 Issue: 6 Pages: 734-737 Pub: 2017 Apr ePub: 2017 Apr 20 Authors Petrov VA,Saltykova IV,Zhukova IA,Alifirova VM,Zhukova NG,Dorofeeva YB,Tyakht AV,Kovarsky BA,Alekseev DG,Kostryukova ES,Mironova YS,Izhboldina OP,Nikitina MA,Perevozchikova TV,Fait EA,Babenko VV,Vakhitova MT,Govorun VM,Sazonov AE
10 πŸ“š
Analysis of the Gut Microflora in Patients With Parkinson`s Disease.
Frontiers in neuroscience (Front Neurosci ) Vol: 13 Issue: Pages: 1184 Pub: 2019 ePub: 2019 Nov 22 Authors Jin M,Li J,Liu F,Lyu N,Wang K,Wang L,Liang S,Tao H,Zhu B,Alkasir R
11 πŸ“š
Association between increased and decreased gut microbiota abundance and Parkinson's disease: A systematic review and subgroup meta-analysis.
Experimental gerontology (Exp Gerontol ) Vol: 191 Issue: Pages: 112444 Pub: 2024 Jun 15 ePub: 2024 Apr 29 Authors Bai F,You L,Lei H,Li X
12 πŸ“š
Association between the relative abundance of butyrate-producing and mucin-degrading taxa and Parkinson's disease.
Neuroscience (Neuroscience ) Vol: 576 Issue: Pages: 149-154 Pub: 2025 May 1 ePub: 2025 May 1 Authors Rust C,van den Heuvel LL,Bardien S,Carr J,Pretorius E,Seedat S,Hemmings SMJ
13 πŸ“š
Association of Helicobacter pylori treatment with Parkinsonism and related disorders: A systematic review and meta-analysis.
Life sciences (Life Sci ) Vol: 281 Issue: Pages: 119767 Pub: 2021 Sep 15 ePub: 2021 Jul 1 Authors Bai F,Li X
14 πŸ“š
Association of Parkinson`s Disease With Microbes and Microbiological Therapy.
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 11 Issue: Pages: 619354 Pub: 2021 ePub: 2021 Mar 8 Authors Chen ZJ,Liang CY,Yang LQ,Ren SM,Xia YM,Cui L,Li XF,Gao BL
15 πŸ“š
Augmentation of Autoantibodies by Helicobacter pylori in Parkinson's Disease Patients May Be Linked to Greater Severity.
PloS one (PLoS One ) Vol: 11 Issue: 4 Pages: e0153725 Pub: 2016 ePub: 2016 Apr 21 Authors Suwarnalata G,Tan AH,Isa H,Gudimella R,Anwar A,Loke MF,Mahadeva S,Lim SY,Vadivelu J
16 πŸ“š
Biomarkers of Parkinson's Disease: From Basic Research to Clinical Practice.
Aging and disease (Aging Dis ) Vol: 15 Issue: 4 Pages: 1813-1830 Pub: 2024 Aug 1 ePub: 2024 Aug 1 Authors Ma ZL,Wang ZL,Zhang FY,Liu HX,Mao LH,Yuan L
17 πŸ“š
Can Gut Microbiota Be a Good Predictor for Parkinson's Disease? A Machine Learning Approach.
Brain sciences (Brain Sci ) Vol: 10 Issue: 4 Pages: Pub: 2020 Apr 19 ePub: 2020 Apr 19 Authors Pietrucci D,Teofani A,Unida V,Cerroni R,Biocca S,Stefani A,Desideri A
18 πŸ“š
Changes in Bacterial Gut Composition in Parkinson's Disease and Their Metabolic Contribution to Disease Development: A Gut Community Reconstruction Approach.
Microorganisms (Microorganisms ) Vol: 12 Issue: 2 Pages: Pub: 2024 Feb 4 ePub: 2024 Feb 4 Authors Forero-RodrΓ­guez J,Zimmermann J,Taubenheim J,Arias-RodrΓ­guez N,Caicedo-Narvaez JD,Best L,Mendieta CV,LΓ³pez-Castiblanco J,GΓ³mez-MuΓ±oz LA,Gonzalez-Santos J,Arboleda H,Fernandez W,Kaleta C,PinzΓ³n A
19 πŸ“š
Changes in Gastrointestinal Microbiome Composition in PD: A Pivotal Role of Covariates.
Frontiers in neurology (Front Neurol ) Vol: 11 Issue: Pages: 1041 Pub: 2020 ePub: 2020 Sep 23 Authors Cosma-Grigorov A,Meixner H,Mrochen A,Wirtz S,Winkler J,Marxreiter F
20 πŸ“š
Changes of Colonic Bacterial Composition in Parkinson`s Disease and Other Neurodegenerative Diseases.
Nutrients (Nutrients ) Vol: 10 Issue: 6 Pages: Pub: 2018 Jun 1 ePub: 2018 Jun 1 Authors Gerhardt S,Mohajeri MH
21 πŸ“š
Characterization of the intestinal microbiota during Citrobacter rodentium infection in a mouse model of infection-triggered Parkinson's disease.
Gut microbes (Gut Microbes ) Vol: 12 Issue: 1 Pages: 1-11 Pub: 2020 Nov 9 ePub: Authors Cannon T,Sinha A,Trudeau LE,Maurice CF,Gruenheid S
22 πŸ“š
Clinical Phenotypes of Parkinson`s Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes.
Biomolecules (Biomolecules ) Vol: 11 Issue: 2 Pages: Pub: 2021 Jan 22 ePub: 2021 Jan 22 Authors Vascellari S,Melis M,Palmas V,Pisanu S,Serra A,Perra D,Santoru ML,Oppo V,Cusano R,Uva P,Atzori L,Morelli M,Cossu G,Manzin A
23 πŸ“š
Clostridium difficile infection and risk of Parkinson's disease: a Swedish population-based cohort study.
European journal of neurology (Eur J Neurol ) Vol: 27 Issue: 11 Pages: 2134-2141 Pub: 2020 Nov ePub: 2020 Jul 9 Authors Kang X,Ploner A,Ludvigsson JF,Williams DM,Larsson H,Pedersen NL,Wirdefeldt K
24 πŸ“š
Colonic bacterial composition in Parkinson`s disease.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 30 Issue: 10 Pages: 1351-60 Pub: 2015 Sep ePub: 2015 Jul 16 Authors Keshavarzian A,Green SJ,Engen PA,Voigt RM,Naqib A,Forsyth CB,Mutlu E,Shannon KM
25 πŸ“š
Comparative analysis of Parkinson's and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion.
NPJ Parkinson's disease (NPJ Parkinsons Dis ) Vol: 11 Issue: 1 Pages: 50 Pub: 2025 Mar 19 ePub: 2025 Mar 19 Authors Krueger ME,Boles JS,Simon ZD,Alvarez SD,McFarland NR,Okun MS,Zimmermann EM,Forsmark CE,Tansey MG
26 πŸ“š
Cyanobacteria, Cyanotoxins, and Neurodegenerative Diseases: Dangerous Liaisons.
International journal of molecular sciences (Int J Mol Sci ) Vol: 22 Issue: 16 Pages: Pub: 2021 Aug 13 ePub: 2021 Aug 13 Authors Sini P,Dang TBC,Fais M,Galioto M,Padedda BM,Lugliè A,Iaccarino C,Crosio C
27 πŸ“š
Diet and the gut microbiome in patients with Parkinson's disease.
NPJ Parkinson's disease (NPJ Parkinsons Dis ) Vol: 10 Issue: 1 Pages: 89 Pub: 2024 Apr 22 ePub: 2024 Apr 22 Authors Kwon D,Zhang K,Paul KC,Folle AD,Del Rosario I,Jacobs JP,Keener AM,Bronstein JM,Ritz B
28 πŸ“š
Difference in gut microbial dysbiotic patterns between body-first and brain-first Parkinson's disease.
Neurobiology of disease (Neurobiol Dis ) Vol: 201 Issue: Pages: 106655 Pub: 2024 Oct 15 ePub: 2024 Aug 30 Authors Park DG,Kang W,Shin IJ,Chalita M,Oh HS,Hyun DW,Kim H,Chun J,An YS,Lee EJ,Yoon JH
29 πŸ“š
Distinct gut microbiome characteristics and dynamics in patients with Parkinson's disease based on the presence of premotor rapid-eye movement sleep behavior disorders.
Microbiome (Microbiome ) Vol: 13 Issue: 1 Pages: 108 Pub: 2025 Apr 30 ePub: 2025 Apr 30 Authors Lee JY,Jo S,Lee J,Choi M,Kim K,Lee S,Kim HS,Bae JW,Chung SJ
30 πŸ“š
Does Gut Microbiota Influence the Course of Parkinson`s Disease? A 3-Year Prospective Exploratory Study in de novo Patients.
Journal of Parkinson`s disease (J Parkinsons Dis ) Vol: 11 Issue: 1 Pages: 159-170 Pub: 2021 ePub: Authors Cilia R,Piatti M,Cereda E,Bolliri C,Caronni S,Ferri V,Cassani E,Bonvegna S,Ferrarese C,Zecchinelli AL,Barichella M,Pezzoli G
31 πŸ“š
Dysbiosis of gut microbiota in a selected population of Parkinson`s patients.
Parkinsonism & related disorders (Parkinsonism Relat Disord ) Vol: 65 Issue: Pages: 124-130 Pub: 2019 Aug ePub: 2019 Jun 3 Authors Pietrucci D,Cerroni R,Unida V,Farcomeni A,Pierantozzi M,Mercuri NB,Biocca S,Stefani A,Desideri A
32 πŸ“š
Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson's Disease from India.
Annals of Indian Academy of Neurology (Ann Indian Acad Neurol ) Vol: 26 Issue: 6 Pages: 908-916 Pub: 2023 Nov-Dec ePub: 2023 Oct 31 Authors Pavan S,Gorthi SP,Prabhu AN,Das B,Mutreja A,Vasudevan K,Shetty V,Ramamurthy T,Ballal M
33 πŸ“š
Early Dysbiosis and Dampened Gut Microbe Oscillation Precede Motor Dysfunction and Neuropathology in Animal Models of Parkinson's Disease.
Journal of Parkinson's disease (J Parkinsons Dis ) Vol: 12 Issue: 8 Pages: 2423-2440 Pub: 2022 ePub: Authors Liang F,Chen CY,Li YP,Ke YC,Ho EP,Jeng CF,Lin CH,Chen SK
34 πŸ“š
Elevated serum anti-Saccharomyces cerevisiae antibody accompanied by gut mycobiota dysbiosis as a biomarker of diagnosis in patients with de novo Parkinson disease.
European journal of neurology (Eur J Neurol ) Vol: 30 Issue: 11 Pages: 3462-3470 Pub: 2023 Nov ePub: 2023 Feb 14 Authors Chen Y,Zhang LY,Fang Y,Li C,Xia DD,Zhang G,Wen Y,Zhang SZ,Hu L,Gu LY,Liu Y,Tian J,Yan YP,Yin XZ,Tao ZH,Zhang BR,Pu JL
35 πŸ“š
Fecal microbiome alterations in treatment-naive de novo Parkinson's disease.
NPJ Parkinson's disease (NPJ Parkinsons Dis ) Vol: 8 Issue: 1 Pages: 129 Pub: 2022 Oct 10 ePub: 2022 Oct 10 Authors Boertien JM,MurtomΓ€ki K,Pereira PAB,van der Zee S,Mertsalmi TH,Levo R,Nojonen T,MΓ€kinen E,Jaakkola E,Laine P,Paulin L,Pekkonen E,Kaasinen V,Auvinen P,Scheperjans F,van Laar T,PPNN Study Group
36 πŸ“š
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naΓ―ve Parkinson's disease patients.
Genome medicine (Genome Med ) Vol: 9 Issue: 1 Pages: 39 Pub: 2017 Apr 28 ePub: 2017 Apr 28 Authors Bedarf JR,Hildebrand F,Coelho LP,Sunagawa S,Bahram M,Goeser F,Bork P,WΓΌllner U
37 πŸ“š
Gastric Helicobacter pylori infection as a cause of idiopathic Parkinson disease and non-arteric anterior optic ischemic neuropathy.
Medical hypotheses (Med Hypotheses ) Vol: 47 Issue: 5 Pages: 413-4 Pub: 1996 Nov ePub: Authors Altschuler E
38 πŸ“š
GMrepo v2: a curated human gut microbiome database with special focus on disease markers and cross-dataset comparison.
Nucleic acids research (Nucleic Acids Res ) Vol: 50 Issue: D1 Pages: D777-D784 Pub: 2022 Jan 7 ePub: Authors Dai D,Zhu J,Sun C,Li M,Liu J,Wu S,Ning K,He LJ,Zhao XM,Chen WH
39 πŸ“š
Gut bacterial deamination of residual levodopa medication for Parkinson`s disease.
BMC biology (BMC Biol ) Vol: 18 Issue: 1 Pages: 137 Pub: 2020 Oct 20 ePub: 2020 Oct 20 Authors van Kessel SP,de Jong HR,Winkel SL,van Leeuwen SS,Nelemans SA,Permentier H,Keshavarzian A,El Aidy S
40 πŸ“š
Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease.
Brain : a journal of neurology (Brain ) Vol: 143 Issue: 8 Pages: 2474-2489 Pub: 2020 Aug 1 ePub: Authors Qian Y,Yang X,Xu S,Huang P,Li B,Du J,He Y,Su B,Xu LM,Wang L,Huang R,Chen S,Xiao Q
41 πŸ“š
Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi-Omics.
Annals of neurology (Ann Neurol ) Vol: 89 Issue: 3 Pages: 546-559 Pub: 2021 Mar ePub: 2021 Jan 11 Authors Tan AH,Chong CW,Lim SY,Yap IKS,Teh CSJ,Loke MF,Song SL,Tan JY,Ang BH,Tan YQ,Kho MT,Bowman J,Mahadeva S,Yong HS,Lang AE
42 πŸ“š
Gut Microbiota Altered in Mild Cognitive Impairment Compared With Normal Cognition in Sporadic Parkinson's Disease.
Frontiers in neurology (Front Neurol ) Vol: 11 Issue: Pages: 137 Pub: 2020 ePub: 2020 Feb 25 Authors Ren T,Gao Y,Qiu Y,Jiang S,Zhang Q,Zhang J,Wang L,Zhang Y,Wang L,Nie K
43 πŸ“š
Gut Microbiota and Metabolome Alterations Associated with Parkinson`s Disease.
mSystems (mSystems ) Vol: 5 Issue: 5 Pages: Pub: 2020 Sep 15 ePub: 2020 Sep 15 Authors Vascellari S,Palmas V,Melis M,Pisanu S,Cusano R,Uva P,Perra D,Madau V,Sarchioto M,Oppo V,Simola N,Morelli M,Santoru ML,Atzori L,Melis M,Cossu G,Manzin A
44 πŸ“š
Gut microbiota are related to Parkinson's disease and clinical phenotype.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 30 Issue: 3 Pages: 350-8 Pub: 2015 Mar ePub: 2014 Dec 5 Authors Scheperjans F,Aho V,Pereira PA,Koskinen K,Paulin L,Pekkonen E,Haapaniemi E,Kaakkola S,Eerola-Rautio J,Pohja M,Kinnunen E,Murros K,Auvinen P
45 πŸ“š
Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.
Nutrients (Nutrients ) Vol: 15 Issue: 20 Pages: Pub: 2023 Oct 13 ePub: 2023 Oct 13 Authors Heravi FS,Naseri K,Hu H
46 πŸ“š
Gut Microbiota Differs Between Parkinson`s Disease Patients and Healthy Controls in Northeast China.
Frontiers in molecular neuroscience (Front Mol Neurosci ) Vol: 12 Issue: Pages: 171 Pub: 2019 ePub: 2019 Jul 11 Authors Li C,Cui L,Yang Y,Miao J,Zhao X,Zhang J,Cui G,Zhang Y
47 πŸ“š
Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis.
European journal of neurology (Eur J Neurol ) Vol: 30 Issue: 11 Pages: 3581-3594 Pub: 2023 Nov ePub: 2023 Jan 18 Authors Kleine Bardenhorst S,Cereda E,Severgnini M,Barichella M,Pezzoli G,Keshavarzian A,Desideri A,Pietrucci D,Aho VTE,Scheperjans F,Hildebrand F,Weis S,Egert M,Karch A,Vital M,RΓΌbsamen N
48 πŸ“š
Gut microbiota from patients with Parkinson's disease causes motor deficits in honeybees.
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue: Pages: 1418857 Pub: 2024 ePub: 2024 Jul 12 Authors Zeng J,Li Y,Yan J,Chang R,Xu M,Zhou G,Meng J,Liu D,Mao Z,Yang Y
49 πŸ“š
Gut microbiota in Parkinson disease in a northern German cohort.
Brain research (Brain Res ) Vol: 1667 Issue: Pages: 41-45 Pub: 2017 Jul 15 ePub: 2017 May 12 Authors Hopfner F,KΓΌnstner A,MΓΌller SH,KΓΌnzel S,Zeuner KE,Margraf NG,Deuschl G,Baines JF,KuhlenbΓ€umer G
50 πŸ“š
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression.
EBioMedicine (EBioMedicine ) Vol: 44 Issue: Pages: 691-707 Pub: 2019 Jun ePub: 2019 Jun 18 Authors Aho VTE,Pereira PAB,Voutilainen S,Paulin L,Pekkonen E,Auvinen P,Scheperjans F
51 πŸ“š
Gut microbiota in patients with Parkinson`s disease in southern China.
Parkinsonism & related disorders (Parkinsonism Relat Disord ) Vol: 53 Issue: Pages: 82-88 Pub: 2018 Aug ePub: Authors Lin A,Zheng W,He Y,Tang W,Wei X,He R,Huang W,Su Y,Huang Y,Zhou H,Xie H
52 πŸ“š
Gut microbiota of Parkinson's disease in an appendectomy cohort: a preliminary study.
Scientific reports (Sci Rep ) Vol: 13 Issue: 1 Pages: 2210 Pub: 2023 Feb 7 ePub: 2023 Feb 7 Authors Nakahara K,Nakane S,Ishii K,Ikeda T,Ando Y
53 πŸ“š
Gut Microbiota, Nitric Oxide, and Microglia as Prerequisites for Neurodegenerative Disorders.
ACS chemical neuroscience (ACS Chem Neurosci ) Vol: 8 Issue: 7 Pages: 1438-1447 Pub: 2017 Jul 19 ePub: 2017 Jul 7 Authors Tse JKY
54 πŸ“š
Gut microbiota-associated taurine metabolism dysregulation in a mouse model of Parkinson's disease.
mSphere (mSphere ) Vol: 8 Issue: 6 Pages: e0043123 Pub: 2023 Dec 20 ePub: 2023 Oct 11 Authors Cui C,Song H,Han Y,Yu H,Li H,Yang Y,Zhang B
55 πŸ“š
Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson's disease patients: A prospective cohort study (HP-PD trial).
PloS one (PLoS One ) Vol: 16 Issue: 5 Pages: e0251042 Pub: 2021 ePub: 2021 May 4 Authors Lolekha P,Sriphanom T,Vilaichone RK
56 πŸ“š
Helicobacter pylori Eradication in Parkinson's Disease: A Randomized Placebo-Controlled Trial.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 35 Issue: 12 Pages: 2250-2260 Pub: 2020 Dec ePub: 2020 Sep 7 Authors Tan AH,Lim SY,Mahadeva S,Loke MF,Tan JY,Ang BH,Chin KP,Mohammad Adnan AF,Ong SMC,Ibrahim AI,Zulkifli N,Lee JK,Lim WT,Teo YT,Kok YL,Ng TY,Tan AGS,Zulkifle IM,Ng CK,Ee SS,Arafin S,Mohamad Shukori K,Vadivelu JS,Marras C,Fox SH,Lang AE
57 πŸ“š
Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 23 Issue: 12 Pages: 1696-700 Pub: 2008 Sep 15 ePub: Authors Lee WY,Yoon WT,Shin HY,Jeon SH,Rhee PL
58 πŸ“š
Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson's disease: a systematic review and meta-analysis.
Journal of neurology (J Neurol ) Vol: 269 Issue: 2 Pages: 703-711 Pub: 2022 Feb ePub: 2021 Feb 22 Authors Zhong R,Chen Q,Zhang X,Li M,Lin W
59 πŸ“š
Helicobacter pylori infection is associated with worse severity of Parkinson's disease.
Parkinsonism & related disorders (Parkinsonism Relat Disord ) Vol: 21 Issue: 3 Pages: 221-5 Pub: 2015 Mar ePub: 2014 Dec 18 Authors Tan AH,Mahadeva S,Marras C,Thalha AM,Kiew CK,Yeat CM,Ng SW,Ang SP,Chow SK,Loke MF,Vadivelu JS,Ibrahim N,Yong HS,Tan CT,Fox SH,Lang AE,Lim SY
60 πŸ“š
High levels of Bifidobacteriaceae are associated with the pathogenesis of Parkinson's disease.
Frontiers in integrative neuroscience (Front Integr Neurosci ) Vol: 16 Issue: Pages: 1054627 Pub: 2022 ePub: 2023 Jan 4 Authors Zuo S,Wang H,Zhao Q,Tang J,Wang M,Zhang Y,Sang M,Tian J,Wang P
61 πŸ“š
Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson`s Disease: A Systematic Review.
Journal of Parkinson`s disease (J Parkinsons Dis ) Vol: Issue: Pages: Pub: 2019 Sep 4 ePub: 2019 Sep 4 Authors Boertien JM,Pereira PAB,Aho VTE,Scheperjans F
62 πŸ“š
Inflammatory microbes and genes as potential biomarkers of Parkinson`s disease.
NPJ biofilms and microbiomes (NPJ Biofilms Microbiomes ) Vol: 8 Issue: 1 Pages: 101 Pub: 2022 Dec 24 ePub: 2022 Dec 24 Authors Nie S,Wang J,Deng Y,Ye Z,Ge Y
63 πŸ“š
Meta-Analysis of Gut Dysbiosis in Parkinson`s Disease.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 35 Issue: 9 Pages: 1626-1635 Pub: 2020 Sep ePub: 2020 Jun 18 Authors Nishiwaki H,Ito M,Ishida T,Hamaguchi T,Maeda T,Kashihara K,Tsuboi Y,Ueyama J,Shimamura T,Mori H,Kurokawa K,Katsuno M,Hirayama M,Ohno K
64 πŸ“š
Meta-analysis of shotgun sequencing of gut microbiota in Parkinson's disease.
NPJ Parkinson's disease (NPJ Parkinsons Dis ) Vol: 10 Issue: 1 Pages: 106 Pub: 2024 May 21 ePub: 2024 May 21 Authors Nishiwaki H,Ueyama J,Ito M,Hamaguchi T,Takimoto K,Maeda T,Kashihara K,Tsuboi Y,Mori H,Kurokawa K,Katsuno M,Hirayama M,Ohno K
65 πŸ“š
Meta-analysis of the Parkinson`s disease gut microbiome suggests alterations linked to intestinal inflammation.
NPJ Parkinson`s disease (NPJ Parkinsons Dis ) Vol: 7 Issue: 1 Pages: 27 Pub: 2021 Mar 10 ePub: 2021 Mar 10 Authors Romano S,Savva GM,Bedarf JR,Charles IG,Hildebrand F,Narbad A
66 πŸ“š
Metagenomic Analysis Reveals Large-Scale Disruptions of the Gut Microbiome in Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 39 Issue: 10 Pages: 1740-1751 Pub: 2024 Oct ePub: 2024 Aug 28 Authors Metcalfe-Roach A,Cirstea MS,Yu AC,Ramay HR,Coker O,Boroomand S,Kharazyan F,Martino D,Sycuro LK,Appel-Cresswell S,Finlay BB
67 πŸ“š
Metagenomics of Parkinson`s disease implicates the gut microbiome in multiple disease mechanisms.
Nature communications (Nat Commun ) Vol: 13 Issue: 1 Pages: 6958 Pub: 2022 Nov 15 ePub: 2022 Nov 15 Authors Wallen ZD,Demirkan A,Twa G,Cohen G,Dean MN,Standaert DG,Sampson TR,Payami H
68 πŸ“š
Microbial biomarker discovery in Parkinson's disease through a network-based approach.
NPJ Parkinson's disease (NPJ Parkinsons Dis ) Vol: 10 Issue: 1 Pages: 203 Pub: 2024 Oct 26 ePub: 2024 Oct 26 Authors Zhao Z,Chen J,Zhao D,Chen B,Wang Q,Li Y,Chen J,Bai C,Guo X,Hu N,Zhang B,Zhao R,Yuan J
69 πŸ“š
Microbiome changes: an indicator of Parkinson`s disease?
Translational neurodegeneration (Transl Neurodegener ) Vol: 8 Issue: Pages: 38 Pub: 2019 ePub: 2019 Dec 24 Authors Haikal C,Chen QQ,Li JY
70 πŸ“š
Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 35 Issue: 7 Pages: 1208-1217 Pub: 2020 Jul ePub: 2020 May 1 Authors Cirstea MS,Yu AC,Golz E,Sundvick K,Kliger D,Radisavljevic N,Foulger LH,Mackenzie M,Huan T,Finlay BB,Appel-Cresswell S
71 πŸ“š
More than constipation - bowel symptoms in Parkinson's disease and their connection to gut microbiota.
European journal of neurology (Eur J Neurol ) Vol: 24 Issue: 11 Pages: 1375-1383 Pub: 2017 Nov ePub: 2017 Sep 11 Authors Mertsalmi TH,Aho VTE,Pereira PAB,Paulin L,Pekkonen E,Auvinen P,Scheperjans F
72 πŸ“š
Neuroprotective effects of probiotics bacteria on animal model of Parkinson`s disease induced by 6-hydroxydopamine: A behavioral, biochemical, and histological study.
Journal of immunoassay & immunochemistry (J Immunoassay Immunochem ) Vol: Issue: Pages: 1-15 Pub: 2020 Oct 20 ePub: 2020 Oct 20 Authors Alipour Nosrani E,Tamtaji OR,Alibolandi Z,Sarkar P,Ghazanfari M,Azami Tameh A,Taghizadeh M,Banikazemi Z,Hadavi R,Naderi Taheri M
73 πŸ“š
New insights from uncultivated genomes of the global human gut microbiome.
Nature (Nature ) Vol: 568 Issue: 7753 Pages: 505-510 Pub: 2019 Apr ePub: 2019 Mar 13 Authors Nayfach S,Shi ZJ,Seshadri R,Pollard KS,Kyrpides NC
74 πŸ“š
Nutritional Intake and Gut Microbiome Composition Predict Parkinson's Disease.
Frontiers in aging neuroscience (Front Aging Neurosci ) Vol: 14 Issue: Pages: 881872 Pub: 2022 ePub: 2022 May 11 Authors Lubomski M,Xu X,Holmes AJ,Muller S,Yang JYH,Davis RL,Sue CM
75 πŸ“š
Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice.
Scientific reports (Sci Rep ) Vol: 8 Issue: 1 Pages: 1275 Pub: 2018 Jan 19 ePub: 2018 Jan 19 Authors Choi JG,Kim N,Ju IG,Eo H,Lim SM,Jang SE,Kim DH,Oh MS
76 πŸ“š
Oral aged garlic (Allium sativum) alleviates ulcerative colitis in mice by improving gut homeostasis.
Food & function (Food Funct ) Vol: 15 Issue: 17 Pages: 8935-8951 Pub: 2024 Aug 27 ePub: 2024 Aug 27 Authors Han D,Guan X,Zhu F,Yang Q,Su D
77 πŸ“š
Oral and gut dysbiosis leads to functional alterations in Parkinson's disease.
NPJ Parkinson's disease (NPJ Parkinsons Dis ) Vol: 8 Issue: 1 Pages: 87 Pub: 2022 Jul 7 ePub: 2022 Jul 7 Authors Jo S,Kang W,Hwang YS,Lee SH,Park KW,Kim MS,Lee H,Yoon HJ,Park YK,Chalita M,Lee JH,Sung H,Lee JY,Bae JW,Chung SJ
78 πŸ“š
Oral and gut microbiome profiles in people with early idiopathic Parkinson's disease.
Communications medicine (Commun Med (Lond) ) Vol: 4 Issue: 1 Pages: 209 Pub: 2024 Oct 23 ePub: 2024 Oct 23 Authors Stagaman K,Kmiecik MJ,Wetzel M,Aslibekyan S,Sonmez TF,Fontanillas P,23andMe Research Team,Tung J,Holmes MV,Walk ST,Houser MC,Norcliffe-Kaufmann L
79 πŸ“š
Parkinson`s Disease and Gut Microbiota.
Annals of nutrition & metabolism (Ann Nutr Metab ) Vol: Issue: Pages: 1-8 Pub: 2021 Sep 9 ePub: 2021 Sep 9 Authors Hirayama M,Ohno K
80 πŸ“š
Parkinson`s disease and Parkinson`s disease medications have distinct signatures of the gut microbiome.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 32 Issue: 5 Pages: 739-749 Pub: 2017 May ePub: 2017 Feb 14 Authors Hill-Burns EM,Debelius JW,Morton JT,Wissemann WT,Lewis MR,Wallen ZD,Peddada SD,Factor SA,Molho E,Zabetian CP,Knight R,Payami H
81 πŸ“š
Parkinson`s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions.
BMC biology (BMC Biol ) Vol: 18 Issue: 1 Pages: 62 Pub: 2020 Jun 9 ePub: 2020 Jun 9 Authors Baldini F,Hertel J,Sandt E,Thinnes CC,Neuberger-Castillo L,Pavelka L,Betsou F,KrΓΌger R,Thiele I,NCER-PD Consortium.
82 πŸ“š
Parkinson's Disease and the Gut Microbiome in Rural California.
Journal of Parkinson's disease (J Parkinsons Dis ) Vol: 12 Issue: 8 Pages: 2441-2452 Pub: 2022 ePub: Authors Zhang K,Paul KC,Jacobs JP,Chou HL,Duarte Folle A,Del Rosario I,Yu Y,Bronstein JM,Keener AM,Ritz B
83 πŸ“š
Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota.
Journal of neurovirology (J Neurovirol ) Vol: 22 Issue: 1 Pages: 22-32 Pub: 2016 Feb ePub: 2015 Jun 20 Authors Dobbs SM,Dobbs RJ,Weller C,Charlett A,Augustin A,Taylor D,Ibrahim MA,Bjarnason I
84 πŸ“š
Plasma Metabolites as Mediators Between Gut Microbiota and Parkinson's Disease: Insights from Mendelian Randomization.
Molecular neurobiology (Mol Neurobiol ) Vol: Issue: Pages: Pub: 2025 Feb 17 ePub: 2025 Feb 17 Authors Chen J,Zhu L,Wang F,Zhu Y,Chen J,Liang C,Liu B,Pang A,Yang X
85 πŸ“š
Porphyromonas gingivalis: A key role in Parkinson's disease with cognitive impairment?
Frontiers in neurology (Front Neurol ) Vol: 13 Issue: Pages: 945523 Pub: 2022 ePub: 2022 Jul 26 Authors Li D,Ren T,Li H,Liao G,Zhang X
86 πŸ“š
Progression of Parkinson`s disease is associated with gut dysbiosis: Two-year follow-up study.
PloS one (PLoS One ) Vol: 12 Issue: 11 Pages: e0187307 Pub: 2017 ePub: 2017 Nov 1 Authors Minato T,Maeda T,Fujisawa Y,Tsuji H,Nomoto K,Ohno K,Hirayama M
87 πŸ“š
Proinflammatory and GABA eating bacteria in Parkinson's disease gut microbiome from a meta-analysis prospective.
NPJ Parkinson's disease (NPJ Parkinsons Dis ) Vol: 11 Issue: 1 Pages: 145 Pub: 2025 Jun 3 ePub: 2025 Jun 3 Authors Marzouk NH,Rashwan HH,El-Hadidi M,Ramadan R,Mysara M
88 πŸ“š
Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson`s disease.
PloS one (PLoS One ) Vol: 13 Issue: 12 Pages: e0208313 Pub: 2018 ePub: 2018 Dec 26 Authors Suzuki A,Ito M,Hamaguchi T,Mori H,Takeda Y,Baba R,Watanabe T,Kurokawa K,Asakawa S,Hirayama M,Ohno K
89 πŸ“š
Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease.
Molecular neurodegeneration (Mol Neurodegener ) Vol: 16 Issue: 1 Pages: 6 Pub: 2021 Feb 8 ePub: 2021 Feb 8 Authors Aho VTE,Houser MC,Pereira PAB,Chang J,Rudi K,Paulin L,Hertzberg V,Auvinen P,Tansey MG,Scheperjans F
90 πŸ“š
Retrospective analysis of diet and gut microbiota diversity and clinical pharmacology outcomes in patients with Parkinsonism syndrome.
Heliyon (Heliyon ) Vol: 10 Issue: 21 Pages: e38645 Pub: 2024 Nov 15 ePub: 2024 Sep 27 Authors Hu Y,Wang H,Zhong Y,Sun Y
91 πŸ“š
Review: Extragastric diseases and Helicobacter pylori.
Helicobacter (Helicobacter ) Vol: 25 Suppl 1 Issue: Pages: e12741 Pub: 2020 Sep ePub: Authors Pellicano R,Ianiro G,Fagoonee S,Settanni CR,Gasbarrini A
92 πŸ“š
Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease.
Metabolic brain disease (Metab Brain Dis ) Vol: 37 Issue: 7 Pages: 2511-2520 Pub: 2022 Oct ePub: 2022 Jul 27 Authors Yan Z,Li R,Shi W,Yao L
93 πŸ“š
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
Parkinsonism & related disorders (Parkinsonism Relat Disord ) Vol: 32 Issue: Pages: 66-72 Pub: 2016 Nov ePub: 2016 Aug 26 Authors Unger MM,Spiegel J,Dillmann KU,Grundmann D,Philippeit H,Bürmann J,Faßbender K,Schwiertz A,SchÀfer KH
94 πŸ“š
Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson`s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder.
mSystems (mSystems ) Vol: 5 Issue: 6 Pages: Pub: 2020 Dec 8 ePub: 2020 Dec 8 Authors Nishiwaki H,Hamaguchi T,Ito M,Ishida T,Maeda T,Kashihara K,Tsuboi Y,Ueyama J,Shimamura T,Mori H,Kurokawa K,Katsuno M,Hirayama M,Ohno K
95 πŸ“š
Sika Deer Velvet Antler Peptide Exerts Neuroprotective Effect in a Parkinson's Disease Model via Regulating Oxidative Damage and Gut Microbiota.
Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 17 Issue: 7 Pages: Pub: 2024 Jul 22 ePub: 2024 Jul 22 Authors Liu Y,Li H,Yang M,Guo J,Sun Z,Wang S,Li R,Pang X,Kim Y,Wang X,Peng Y
96 πŸ“š
Specific Bacterial Taxa and Their Metabolite, DHPS, May Be Linked to Gut Dyshomeostasis in Patients with Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Nutrients (Nutrients ) Vol: 17 Issue: 9 Pages: Pub: 2025 May 6 ePub: 2025 May 6 Authors Christopher CJ,Morgan KH,Tolleson CM,Trudell R,Fernandez-Romero R,Rice L,Abiodun BA,Vickery Z,Jones KA,Woodall BM,Nagy C,Mieczkowski PA,Bowen G,Campagna SR,Ellis JC
97 πŸ“š
Sphingobacterium spiritivorum septicaemia associated with cellulitis in a patient with Parkinson's disease.
BMJ case reports (BMJ Case Rep ) Vol: 2016 Issue: Pages: Pub: 2016 May 9 ePub: 2016 May 9 Authors Anthony JM,Verma R
98 πŸ“š
Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features.
Science China. Life sciences (Sci China Life Sci ) Vol: 60 Issue: 11 Pages: 1223-1233 Pub: 2017 Nov ePub: 2017 May 20 Authors Li W,Wu X,Hu X,Wang T,Liang S,Duan Y,Jin F,Qin B
99 πŸ“š
Study of the gut microbiome in Egyptian patients with Parkinson's Disease.
BMC microbiology (BMC Microbiol ) Vol: 23 Issue: 1 Pages: 196 Pub: 2023 Jul 22 ePub: 2023 Jul 22 Authors Mehanna M,AbuRaya S,Ahmed SM,Ashmawy G,Ibrahim A,AbdelKhaliq E
100 πŸ“š
Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson's disease.
Cell reports (Cell Rep ) Vol: 34 Issue: 9 Pages: 108807 Pub: 2021 Mar 2 ePub: Authors Rosario D,Bidkhori G,Lee S,Bedarf J,Hildebrand F,Le Chatelier E,Uhlen M,Ehrlich SD,Proctor G,WΓΌllner U,Mardinoglu A,Shoaie S
101 πŸ“š
The antibodies against Bordetella pertussis in sera of patients with Parkinson's disease and other non-neurological diseases.
Acta neurologica Scandinavica (Acta Neurol Scand ) Vol: 110 Issue: 2 Pages: 113-7 Pub: 2004 Aug ePub: Authors Fiszer U,Tomik B,Grzesiowski P,Krygowska-Wajs A,Walory J,Michalowska M,Palasik W
102 πŸ“š
The Association Between the Gut Microbiota and Parkinson`s Disease, a Meta-Analysis.
Frontiers in aging neuroscience (Front Aging Neurosci ) Vol: 13 Issue: Pages: 636545 Pub: 2021 ePub: 2021 Feb 12 Authors Shen T,Yue Y,He T,Huang C,Qu B,Lv W,Lai HY
103 πŸ“š
The effect of supplementation with prebiotic fiber on the gut microbiota of a group of older people with Parkinson's disease from the city of Santiago de Chile. A pilot study.
Nutricion hospitalaria (Nutr Hosp ) Vol: Issue: Pages: Pub: 2025 Feb 25 ePub: 2025 Feb 25 Authors GarcΓ­a Milla P,Nieto MartΓ­nez G,Maulen M,Tapia C,DΓ­az W
104 πŸ“š
The gut in Parkinson`s disease: Bottom-up, top-down, or neither?
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (Neurogastroenterol Motil ) Vol: 32 Issue: 1 Pages: e13777 Pub: 2020 Jan ePub: Authors Leclair-Visonneau L,Neunlist M,Derkinderen P,Lebouvier T
105 πŸ“š
The Gut Microbiome in Parkinson`s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies.
Frontiers in aging neuroscience (Front Aging Neurosci ) Vol: 14 Issue: Pages: 875261 Pub: 2022 ePub: 2022 May 17 Authors Lubomski M,Xu X,Holmes AJ,Muller S,Yang JYH,Davis RL,Sue CM
106 πŸ“š
The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 33 Issue: 1 Pages: 88-98 Pub: 2018 Jan ePub: 2017 Aug 26 Authors Heintz-Buschart A,Pandey U,Wicke T,Sixel-DΓΆring F,Janzen A,Sittig-Wiegand E,Trenkwalder C,Oertel WH,Mollenhauer B,Wilmes P
107 πŸ“š
The role of HLA-DR on plasmacytoid dendritic cells in mediating the effects of Butyrivibrio gut microbiota on Parkinson's disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (Neurol Sci ) Vol: 45 Issue: 8 Pages: 3809-3815 Pub: 2024 Aug ePub: 2024 Mar 19 Authors Wang Z,Xia H,Feng T,Aibibuli A,Zhang M,Yang X
108 πŸ“š
Understanding Parkinson's: The microbiome and machine learning approach.
Maturitas (Maturitas ) Vol: 193 Issue: Pages: 108185 Pub: 2025 Feb ePub: 2024 Dec 23 Authors Rojas-Velazquez D,Kidwai S,Liu TC,El-Yacoubi MA,Garssen J,Tonda A,Lopez-Rincon A
109 πŸ“š
Unraveling gut microbiota in Parkinson`s disease and atypical parkinsonism.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: Issue: Pages: Pub: 2018 Dec 21 ePub: 2018 Dec 21 Authors Barichella M,Severgnini M,Cilia R,Cassani E,Bolliri C,Caronni S,Ferri V,Cancello R,Ceccarani C,Faierman S,Pinelli G,De Bellis G,Zecca L,Cereda E,Consolandi C,Pezzoli G
110 πŸ“š
Urolithins: potential biomarkers of gut dysbiosis and disease stage in Parkinson's patients.
Food & function (Food Funct ) Vol: 13 Issue: 11 Pages: 6306-6316 Pub: 2022 Jun 6 ePub: 2022 Jun 6 Authors Romo-Vaquero M,FernΓ‘ndez-Villalba E,Gil-Martinez AL,Cuenca-Bermejo L,EspΓ­n JC,Herrero MT,Selma MV
111 πŸ“š
Yeast Prion Protein Sup35 Initiates a-Synuclein Pathology in Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 39 Issue: 5 Pages: 766-767 Pub: 2024 May ePub: 2024 Apr 16 Authors Wang Y,Li H,Song N,Xie J

Treatment Substances

The Studies below identify substances that has been tried with positive changes (for at least some symptoms in the study). Check if it has already been reviewed.

112 πŸ“š
1,25-Dyhydroxyvitamin D3 attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy.
Biochemical and biophysical research communications (Biochem Biophys Res Commun ) Vol: 451 Issue: 1 Pages: 142-7 Pub: 2014 Aug 15 ePub: 2014 Jul 29 Authors Jang W,Kim HJ,Li H,Jo KD,Lee MK,Song SH,Yang HO
113 πŸ“š
6-Shogaol, a ginger product, modulates neuroinflammation: a new approach to neuroprotection.
Neuropharmacology (Neuropharmacology ) Vol: 63 Issue: 2 Pages: 211-23 Pub: 2012 Aug ePub: 2012 Mar 23 Authors Ha SK,Moon E,Ju MS,Kim DH,Ryu JH,Oh MS,Kim SY
114 πŸ“š
6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson's disease models via anti-neuroinflammation.
Acta pharmacologica Sinica (Acta Pharmacol Sin ) Vol: 34 Issue: 9 Pages: 1131-9 Pub: 2013 Sep ePub: 2013 Jul 1 Authors Park G,Kim HG,Ju MS,Ha SK,Park Y,Kim SY,Oh MS
115 πŸ“š
A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease.
Annals of neurology (Ann Neurol ) Vol: 32 Suppl Issue: Pages: S128-32 Pub: 1992 ePub: Authors Fahn S
116 πŸ“š
A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone.
Phytotherapy research : PTR (Phytother Res ) Vol: 30 Issue: 8 Pages: 1219-29 Pub: 2016 Aug ePub: 2016 May 11 Authors Javidi S,Razavi BM,Hosseinzadeh H
117 πŸ“š
Adult nutrient intake as a risk factor for Parkinson's disease.
International journal of epidemiology (Int J Epidemiol ) Vol: 28 Issue: 6 Pages: 1102-9 Pub: 1999 Dec ePub: Authors Johnson CC,Gorell JM,Rybicki BA,Sanders K,Peterson EL
118 πŸ“š
Akkermansia muciniphila in neuropsychiatric disorders: friend or foe?
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 13 Issue: Pages: 1224155 Pub: 2023 ePub: 2023 Jul 10 Authors Lei W,Cheng Y,Gao J,Liu X,Shao L,Kong Q,Zheng N,Ling Z,Hu W
119 πŸ“š
Akkermansia muciniphila Is Beneficial to a Mouse Model of Parkinson's Disease, via Alleviated Neuroinflammation and Promoted Neurogenesis, with Involvement of SCFAs.
Brain sciences (Brain Sci ) Vol: 14 Issue: 3 Pages: Pub: 2024 Feb 29 ePub: 2024 Feb 29 Authors Qiao CM,Huang WY,Zhou Y,Quan W,Niu GY,Li T,Zhang MX,Wu J,Zhao LP,Zhao WJ,Cui C,Shen YQ
120 πŸ“š
Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential.
Biochimica et biophysica acta (Biochim Biophys Acta ) Vol: 1790 Issue: 10 Pages: 1149-60 Pub: 2009 Oct ePub: 2009 Aug 4 Authors Shay KP,Moreau RF,Smith EJ,Smith AR,Hagen TM
121 πŸ“š
Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism.
Brain research (Brain Res ) Vol: 1505 Issue: Pages: 68-74 Pub: 2013 Apr 10 ePub: 2013 Feb 13 Authors Jalali-Nadoushan M,Roghani M
122 πŸ“š
Alpha-tocopherol: looking beyond an antioxidant.
Molecular vision (Mol Vis ) Vol: 15 Issue: Pages: 855-60 Pub: 2009 ePub: 2009 Apr 23 Authors Engin KN
123 πŸ“š
Ameliorating effects of curcumin on 6-OHDA-induced dopaminergic denervation, glial response, and SOD1 reduction in the striatum of hemiparkinsonian mice.
European review for medical and pharmacological sciences (Eur Rev Med Pharmacol Sci ) Vol: 17 Issue: 10 Pages: 1360-8 Pub: 2013 May ePub: Authors Tripanichkul W,Jaroensuppaperch EO
124 πŸ“š
An Overview of the Neuropharmacological Potential of Thymoquinone and its Targeted Delivery Prospects for CNS Disorder.
Current drug metabolism (Curr Drug Metab ) Vol: 23 Issue: 6 Pages: 447-459 Pub: 2022 ePub: Authors Verma R,Sartaj A,Qizilbash FF,Ghoneim MM,Alshehri S,Imam SS,Kala C,Alam MS,Gilani SJ,Taleuzzaman M
125 πŸ“š
Anti oxidative/neuro-inflammation properties of Withania somnifera root extract on rotenone induced stress in rat brain.
Bioinformation (Bioinformation ) Vol: 19 Issue: 6 Pages: 729-738 Pub: 2023 ePub: 2023 Jun 30 Authors Epuri V,Prathap L,Reddy V,Krishnan M
126 πŸ“š
Antioxidant activity of ß-carotene compounds in different in vitro assays.
Molecules (Basel, Switzerland) (Molecules ) Vol: 16 Issue: 2 Pages: 1055-69 Pub: 2011 Jan 25 ePub: 2011 Jan 25 Authors Mueller L,Boehm V
127 πŸ“š
Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View.
Current neuropharmacology (Curr Neuropharmacol ) Vol: 14 Issue: 3 Pages: 260-71 Pub: 2016 ePub: Authors Filograna R,Beltramini M,Bubacco L,Bisaglia M
128 πŸ“š
Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH.
Neuroscience letters (Neurosci Lett ) Vol: 244 Issue: 1 Pages: 33-6 Pub: 1998 Mar 6 ePub: Authors Seitz G,Gebhardt S,Beck JF,BΓΆhm W,Lode HN,Niethammer D,Bruchelt G
129 πŸ“š
Ashwagandha- Withania somnifera (L.) Dunal as a multipotent neuroprotective remedy for genetically induced motor dysfunction and cellular toxicity in human neurodegenerative disease models of Drosophila.
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 318 Issue: Pt A Pages: 116897 Pub: 2024 Jan 10 ePub: 2023 Jul 11 Authors Murthy MN,Shyamala BV
130 πŸ“š
Associations between B Vitamins and Parkinson's Disease.
Nutrients (Nutrients ) Vol: 7 Issue: 9 Pages: 7197-208 Pub: 2015 Aug 27 ePub: 2015 Aug 27 Authors Shen L
131 πŸ“š
Benefits of Vitamins in the Treatment of Parkinson's Disease.
Oxidative medicine and cellular longevity (Oxid Med Cell Longev ) Vol: 2019 Issue: Pages: 9426867 Pub: 2019 ePub: 2019 Feb 20 Authors Zhao X,Zhang M,Li C,Jiang X,Su Y,Zhang Y
132 πŸ“š
Bifidobacterium infantis and Bifidobacterium breve Improve Symptomatology and Neuronal Damage in Neurodegenerative Disease: A Systematic Review.
Nutrients (Nutrients ) Vol: 17 Issue: 3 Pages: Pub: 2025 Jan 22 ePub: 2025 Jan 22 Authors Reiriz M,BeltrΓ‘n-Velasco AI,Echeverry-Alzate V,MartΓ­nez-Miguel E,GΓ³mez-Senent S,Uceda S,Clemente-SuΓ‘rez VJ
133 πŸ“š
Biochemical and clinical effects of Whey protein supplementation in Parkinson's disease: A pilot study.
Journal of the neurological sciences (J Neurol Sci ) Vol: 367 Issue: Pages: 162-70 Pub: 2016 Aug 15 ePub: 2016 May 31 Authors Tosukhowong P,Boonla C,Dissayabutra T,Kaewwilai L,Muensri S,Chotipanich C,Joutsa J,Rinne J,Bhidayasiri R
134 πŸ“š
Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils.
Current pharmaceutical design (Curr Pharm Des ) Vol: 14 Issue: 29 Pages: 3106-19 Pub: 2008 ePub: Authors Baser KH
135 πŸ“š
Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
The European journal of neuroscience (Eur J Neurosci ) Vol: 28 Issue: 3 Pages: 610-7 Pub: 2008 Aug ePub: Authors Anderson DW,Bradbury KA,Schneider JS
136 πŸ“š
Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway.
Brain research (Brain Res ) Vol: 921 Issue: 1-2 Pages: 115-21 Pub: 2001 Dec 7 ePub: Authors Morgan WW,Nelson JF
137 πŸ“š
Chronic treatment with carvacrol improves passive avoidance memory in a rat model of Parkinson's disease.
Arquivos de neuro-psiquiatria (Arq Neuropsiquiatr ) Vol: 76 Issue: 2 Pages: 71-77 Pub: 2018 Feb ePub: Authors Haddadi H,Rajaei Z,Alaei H,Shahidani S
138 πŸ“š
Codrugs linking L-dopa and sulfur-containing antioxidants: new pharmacological tools against Parkinson's disease.
Journal of medicinal chemistry (J Med Chem ) Vol: 52 Issue: 2 Pages: 559-63 Pub: 2009 Jan 22 ePub: Authors Pinnen F,Cacciatore I,Cornacchia C,Sozio P,Cerasa LS,Iannitelli A,Nasuti C,Cantalamessa F,Sekar D,Gabbianelli R,Falcioni ML,Di Stefano A
139 πŸ“š
Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease.
Neuroscience letters (Neurosci Lett ) Vol: 341 Issue: 3 Pages: 201-4 Pub: 2003 May 8 ePub: Authors MΓΌller T,BΓΌttner T,Gholipour AF,Kuhn W
140 πŸ“š
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Journal of neurochemistry (J Neurochem ) Vol: 109 Issue: 5 Pages: 1427-39 Pub: 2009 Jun ePub: 2009 Mar 28 Authors Yang L,Calingasan NY,Wille EJ,Cormier K,Smith K,Ferrante RJ,Beal MF
141 πŸ“š
Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol.
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 127 Issue: 2 Pages: 515-20 Pub: 2010 Feb 3 ePub: 2009 Oct 13 Authors Dugasani S,Pichika MR,Nadarajah VD,Balijepalli MK,Tandra S,Korlakunta JN
142 πŸ“š
Creatine and cyclocreatine attenuate MPTP neurotoxicity.
Experimental neurology (Exp Neurol ) Vol: 157 Issue: 1 Pages: 142-9 Pub: 1999 May ePub: Authors Matthews RT,Ferrante RJ,Klivenyi P,Yang L,Klein AM,Mueller G,Kaddurah-Daouk R,Beal MF
143 πŸ“š
Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial.
Neurology (Neurology ) Vol: 67 Issue: 7 Pages: 1262-4 Pub: 2006 Oct 10 ePub: Authors Bender A,Koch W,Elstner M,Schombacher Y,Bender J,Moeschl M,Gekeler F,MΓΌller-Myhsok B,Gasser T,Tatsch K,Klopstock T
144 πŸ“š
Curcumin has neuroprotection effect on homocysteine rat model of Parkinson.
Journal of molecular neuroscience : MN (J Mol Neurosci ) Vol: 47 Issue: 2 Pages: 234-42 Pub: 2012 Jun ePub: 2012 Mar 15 Authors Mansouri Z,Sabetkasaei M,Moradi F,Masoudnia F,Ataie A
145 πŸ“š
Curcumin Regulates Gut Microbiota and Exerts a Neuroprotective Effect in the MPTP Model of Parkinson's Disease.
Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2022 Issue: Pages: 9110560 Pub: 2022 ePub: 2022 Nov 24 Authors Zhu H,Zhang H,Hou B,Xu B,Ji L,Wu Y
146 πŸ“š
Curcumin: a potential neuroprotective agent in Parkinson's disease.
Current pharmaceutical design (Curr Pharm Des ) Vol: 18 Issue: 1 Pages: 91-9 Pub: 2012 ePub: Authors Mythri RB,Bharath MM
147 πŸ“š
Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 12 Issue: Pages: 887407 Pub: 2022 ePub: 2022 Aug 10 Authors Cui C,Han Y,Li H,Yu H,Zhang B,Li G
148 πŸ“š
DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group.
Archives of neurology (Arch Neurol ) Vol: 46 Issue: 10 Pages: 1052-60 Pub: 1989 Oct ePub: Authors
149 πŸ“š
Deciphering the mechanisms underlying the neuroprotective potential of kaempferol: a comprehensive investigation.
Naunyn-Schmiedeberg's archives of pharmacology (Naunyn Schmiedebergs Arch Pharmacol ) Vol: Issue: Pages: Pub: 2024 Oct 16 ePub: 2024 Oct 16 Authors Chaubey S,Singh L
150 πŸ“š
Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study.
Neurology (Neurology ) Vol: 47 Issue: 3 Pages: 644-50 Pub: 1996 Sep ePub: Authors Hellenbrand W,Boeing H,Robra BP,Seidler A,Vieregge P,Nischan P,Joerg J,Oertel WH,Schneider E,Ulm G
151 πŸ“š
Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 12 Issue: 2 Pages: 190-6 Pub: 1997 Mar ePub: Authors Scheider WL,Hershey LA,Vena JE,Holmlund T,Marshall JR,Freudenheim
152 πŸ“š
Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 32 Issue: 11 Pages: 1631-1636 Pub: 2017 Nov ePub: 2017 Sep 7 Authors Yang F,Wolk A,HΓ₯kansson N,Pedersen NL,Wirdefeldt K
153 πŸ“š
Direct antioxidant properties of creatine.
Biochemical and biophysical research communications (Biochem Biophys Res Commun ) Vol: 290 Issue: 1 Pages: 47-52 Pub: 2002 Jan 11 ePub: Authors Lawler JM,Barnes WS,Wu G,Song W,Demaree S
154 πŸ“š
Disclosing the potential of eleganolone for Parkinson's disease therapeutics: Neuroprotective and anti-inflammatory activities.
Pharmacological research (Pharmacol Res ) Vol: 168 Issue: Pages: 105589 Pub: 2021 Jun ePub: 2021 Mar 31 Authors Silva J,Alves C,Pinteus S,Susano P,SimΓ΅es M,Guedes M,Martins A,Rehfeldt S,Gaspar H,Goettert M,Alfonso A,Pedrosa R
155 πŸ“š
Effect of arctigenin on neurological diseases: A review.
Journal of ethnopharmacology (J Ethnopharmacol ) Vol: 315 Issue: Pages: 116642 Pub: 2023 Oct 28 ePub: 2023 May 24 Authors Li M,Jiang H,Wang Y,Xu Z,Xu H,Chen Y,Zhu J,Lin Z,Zhang M
156 πŸ“š
Effect of Levodopa Initiation on the Gut Microbiota in Parkinson's Disease.
Frontiers in neurology (Front Neurol ) Vol: 12 Issue: Pages: 574529 Pub: 2021 ePub: 2021 Mar 4 Authors Palacios N,Hannoun A,Flahive J,Ward D,Goostrey K,Deb A,Smith KM
157 πŸ“š
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
Archives of neurology (Arch Neurol ) Vol: 59 Issue: 10 Pages: 1541-50 Pub: 2002 Oct ePub: Authors Shults CW,Oakes D,Kieburtz K,Beal MF,Haas R,Plumb S,Juncos JL,Nutt J,Shoulson I,Carter J,Kompoliti K,Perlmutter JS,Reich S,Stern M,Watts RL,Kurlan R,Molho E,Harrison M,Lew M,Parkinson Study Group.
158 πŸ“š
Evaluation of Neuroprotective Effect of Gut Microbe in Parkinson's Disease: An In Silico and In Vivo Approach.
Neuromolecular medicine (Neuromolecular Med ) Vol: 26 Issue: 1 Pages: 32 Pub: 2024 Aug 1 ePub: 2024 Aug 1 Authors Bhardwaj K,Rajawat NK,Mathur N,Kaushik A
159 πŸ“š
Exploring the Neuroprotective Mechanism of Curcumin Inhibition of Intestinal Inflammation against Parkinson's Disease Based on the Gut-Brain Axis.
Pharmaceuticals (Basel, Switzerland) (Pharmaceuticals (Basel) ) Vol: 16 Issue: 1 Pages: Pub: 2022 Dec 27 ePub: 2022 Dec 27 Authors Zhong L,Cai B,Wang Q,Li X,Xu W,Chen T
160 πŸ“š
Fermented Soy Products: Beneficial Potential in Neurodegenerative Diseases.
Foods (Basel, Switzerland) (Foods ) Vol: 10 Issue: 3 Pages: Pub: 2021 Mar 18 ePub: 2021 Mar 18 Authors Jang CH,Oh J,Lim JS,Kim HJ,Kim JS
161 πŸ“š
Fucoidan ameliorates rotenone-induced Parkinsonism in mice by regulating the microbiota-gut-brain axis.
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 283 Issue: Pt 2 Pages: 137373 Pub: 2024 Nov 7 ePub: 2024 Nov 7 Authors Yang X,Zhang X,Ma Y,Li S,Wang Q,Hong JS,Yu G,Qi B,Wang J,Liu C,Shang Q,Wu X,Zhao J
162 πŸ“š
Green Tea, A Medicinal Food with Promising Neurological Benefits.
Current neuropharmacology (Curr Neuropharmacol ) Vol: 19 Issue: 3 Pages: 349-359 Pub: 2021 ePub: Authors Akbarialiabad H,Dahroud MD,Khazaei MM,Razmeh S,Zarshenas MM
163 πŸ“š
Gut microbiota regulation by Lactiplantibacillus plantarum SG5 enhances mitochondrial function in Parkinson's disease mice via the GLP-1/PGC-1a pathway.
The Journal of nutritional biochemistry (J Nutr Biochem ) Vol: Issue: Pages: 109954 Pub: 2025 May 12 ePub: 2025 May 12 Authors Qi Y,Xie S,Chen J,Zhang C,Ma X,Yu Y,Yu X,Wang Y
164 πŸ“š
Hericium erinaceus mycelium and its isolated erinacine A protection from MPTP-induced neurotoxicity through the ER stress, triggering an apoptosis cascade.
Journal of translational medicine (J Transl Med ) Vol: 14 Issue: Pages: 78 Pub: 2016 Mar 18 ePub: 2016 Mar 18 Authors Kuo HC,Lu CC,Shen CH,Tung SY,Hsieh MC,Lee KC,Lee LY,Chen CC,Teng CC,Huang WS,Chen TC,Lee KF
165 πŸ“š
High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease.
Journal of neuroscience research (J Neurosci Res ) Vol: 86 Issue: 9 Pages: 2083-90 Pub: 2008 Jul ePub: Authors Jia H,Li X,Gao H,Feng Z,Li X,Zhao L,Jia X,Zhang H,Liu J
166 πŸ“š
Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice.
Inflammopharmacology (Inflammopharmacology ) Vol: 16 Issue: 2 Pages: 96-9 Pub: 2008 Apr ePub: Authors Rajeswari A,Sabesan M
167 πŸ“š
Intake of antioxidant vitamins and risk of Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society (Mov Disord ) Vol: 31 Issue: 12 Pages: 1909-1914 Pub: 2016 Dec ePub: 2016 Oct 27 Authors Hughes KC,Gao X,Kim IY,Rimm EB,Wang M,Weisskopf MG,Schwarzschild MA,Ascherio A
168 πŸ“š
Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis.
The Lancet. Neurology (Lancet Neurol ) Vol: 4 Issue: 6 Pages: 362-5 Pub: 2005 Jun ePub: Authors Etminan M,Gill SS,Samii A
169 πŸ“š
Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk.
Neurology (Neurology ) Vol: 59 Issue: 8 Pages: 1161-9 Pub: 2002 Oct 22 ePub: Authors Zhang SM,HernΓ‘n MA,Chen H,Spiegelman D,Willett WC,Ascherio A
170 πŸ“š
Ketogenic diet protects MPTP-induced mouse model of Parkinson's disease via altering gut microbiota and metabolites.
MedComm (MedComm (2020) ) Vol: 4 Issue: 3 Pages: e268 Pub: 2023 Jun ePub: 2023 May 16 Authors Jiang Z,Wang X,Zhang H,Yin J,Zhao P,Yin Q,Wang Z
171 πŸ“š
Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature.
International journal of molecular sciences (Int J Mol Sci ) Vol: 25 Issue: 5 Pages: Pub: 2024 Mar 5 ePub: 2024 Mar 5 Authors BeltrΓ‘n-Velasco AI,Reiriz M,Uceda S,Echeverry-Alzate V
172 πŸ“š
Lactobacillus reuteri-derived ?-amino butyric acid alleviates MPTP-induced Parkinson's disease through inhibiting ferroptosis via the AKT-GSK3ß-GPX4 axis.
NPJ Parkinson's disease (NPJ Parkinsons Dis ) Vol: 11 Issue: 1 Pages: 149 Pub: 2025 Jun 4 ePub: 2025 Jun 4 Authors Dong X,Yang T,Jin Z
173 πŸ“š
Lipoic acid alleviates L-DOPA-induced dyskinesia in 6-OHDA parkinsonian rats via anti-oxidative stress.
Molecular medicine reports (Mol Med Rep ) Vol: 17 Issue: 1 Pages: 1118-1124 Pub: 2018 Jan ePub: 2017 Nov 6 Authors Zhang SF,Xie CL,Lin JY,Wang MH,Wang XJ,Liu ZG
174 πŸ“š
Lipoic acid protects dopaminergic neurons in LPS-induced Parkinson's disease model.
Metabolic brain disease (Metab Brain Dis ) Vol: 30 Issue: 5 Pages: 1217-26 Pub: 2015 Oct ePub: 2015 Jun 19 Authors Li YH,He Q,Yu JZ,Liu CY,Feng L,Chai Z,Wang Q,Zhang HZ,Zhang GX,Xiao BG,Ma CG
175 πŸ“š
Lycopene as the most efficient biological carotenoid singlet oxygen quencher.
Archives of biochemistry and biophysics (Arch Biochem Biophys ) Vol: 274 Issue: 2 Pages: 532-8 Pub: 1989 Nov 1 ePub: Authors Di Mascio P,Kaiser S,Sies H
176 πŸ“š
Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system.
Neurochemistry international (Neurochem Int ) Vol: 57 Issue: 5 Pages: 579-87 Pub: 2010 Nov ePub: 2010 Jul 17 Authors Sandhir R,Mehrotra A,Kamboj SS
177 πŸ“š
Melatonin fails to protect against long-term MPTP-induced dopamine depletion in mouse striatum.
Neurotoxicity research (Neurotox Res ) Vol: 1 Issue: 4 Pages: 261-9 Pub: 2000 Apr ePub: Authors van der Schyf CJ,Castagnoli K,Palmer S,Hazelwood L,Castagnoli N Jr
178 πŸ“š
Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J ) Vol: 15 Issue: 1 Pages: 164-170 Pub: 2001 Jan ePub: Authors Dabbeni-Sala F,Di Santo S,Franceschini D,Skaper SD,Giusti P
179 πŸ“š
Membrane vesicles from lactobacillus acidophilus reduce intestinal inflammation and increase 5-HT in the substantia nigra of rats with parkinson's disease.
Archives of medical research (Arch Med Res ) Vol: 56 Issue: 3 Pages: 103143 Pub: 2024 Dec 19 ePub: 2024 Dec 19 Authors Sheikh K,Arasteh J,Tajabadi Ebrahimi M,Hesampour A
180 πŸ“š
N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data.
PloS one (PLoS One ) Vol: 11 Issue: 6 Pages: e0157602 Pub: 2016 ePub: 2016 Jun 16 Authors Monti DA,Zabrecky G,Kremens D,Liang TW,Wintering NA,Cai J,Wei X,Bazzan AJ,Zhong L,Bowen B,Intenzo CM,Iacovitti L,Newberg AB
181 πŸ“š
N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why.
Free radical research (Free Radic Res ) Vol: 52 Issue: 7 Pages: 751-762 Pub: 2018 Jul ePub: 2018 May 9 Authors Aldini G,Altomare A,Baron G,Vistoli G,Carini M,Borsani L,Sergio F
182 πŸ“š
N-Acetylcysteine boosts brain and blood glutathione in Gaucher and Parkinson diseases.
Clinical neuropharmacology (Clin Neuropharmacol ) Vol: 36 Issue: 4 Pages: 103-6 Pub: 2013 Jul-Aug ePub: Authors Holmay MJ,Terpstra M,Coles LD,Mishra U,Ahlskog M,Γ–z G,Cloyd JC,Tuite PJ
183 πŸ“š
Neuroprotective effect of Bacillus subtilis in haloperidol induced rat model, targeting the microbiota-gut-brain axis.
Journal of molecular histology (J Mol Histol ) Vol: 56 Issue: 1 Pages: 18 Pub: 2024 Dec 3 ePub: 2024 Dec 3 Authors Rout M,Kar DM,Dubey D,Kispotta S,Sarangi P,Prusty SK
184 πŸ“š
Neuroprotective effect of lycopene against MPTP induced experimental Parkinson's disease in mice.
Neuroscience letters (Neurosci Lett ) Vol: 599 Issue: Pages: 12-9 Pub: 2015 Jul 10 ePub: 2015 May 14 Authors Prema A,Janakiraman U,Manivasagam T,Thenmozhi AJ
185 πŸ“š
Neuroprotective properties of curcumin in toxin-base animal models of Parkinson's disease: a systematic experiment literatures review.
BMC complementary and alternative medicine (BMC Complement Altern Med ) Vol: 17 Issue: 1 Pages: 412 Pub: 2017 Aug 17 ePub: 2017 Aug 17 Authors Wang XS,Zhang ZR,Zhang MM,Sun MX,Wang WW,Xie CL
186 πŸ“š
Niacin improved rigidity and bradykinesia in a Parkinson's disease patient but also caused unacceptable nightmares and skin rash--a case report.
Nutritional neuroscience (Nutr Neurosci ) Vol: 8 Issue: 5-6 Pages: 327-9 Pub: 2005 Oct-Dec ePub: Authors Alisky JM
187 πŸ“š
Nicotine from edible Solanaceae and risk of Parkinson disease.
Annals of neurology (Ann Neurol ) Vol: 74 Issue: 3 Pages: 472-7 Pub: 2013 Sep ePub: 2013 May 9 Authors Nielsen SS,Franklin GM,Longstreth WT,Swanson PD,Checkoway H
188 πŸ“š
Nigella sativa Oil Reduces LPS-Induced Microglial Inflammation: An Evaluation on M (1)/M (2) Balance.
Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2022 Issue: Pages: 5639226 Pub: 2022 ePub: 2022 Jun 14 Authors Hosseini A,Baradaran Rahimi V,Rakhshandeh H,Askari VR
189 πŸ“š
Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope?
Clinical interventions in aging (Clin Interv Aging ) Vol: 11 Issue: Pages: 1601-1608 Pub: 2016 ePub: 2016 Nov 11 Authors Georgescu D,Ancusa OE,Georgescu LA,Ionita I,Reisz D
190 πŸ“š
Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall.
BioMed research international (Biomed Res Int ) Vol: 2015 Issue: Pages: 791978 Pub: 2015 ePub: 2015 Aug 2 Authors Zanetti M,Grillo A,Losurdo P,Panizon E,Mearelli F,Cattin L,Barazzoni R,Carretta R
191 πŸ“š
Oral Administration of Probiotic Bifidobacterium breve Improves Facilitation of Hippocampal Memory Extinction via Restoration of Aberrant Higher Induction of Neuropsin in an MPTP-Induced Mouse Model of Parkinson's Disease.
Biomedicines (Biomedicines ) Vol: 9 Issue: 2 Pages: Pub: 2021 Feb 8 ePub: 2021 Feb 8 Authors Ishii T,Furuoka H,Kaya M,Kuhara T
192 πŸ“š
Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients.
European journal of clinical investigation (Eur J Clin Invest ) Vol: 31 Issue: 2 Pages: 171-8 Pub: 2001 Feb ePub: Authors Micke P,Beeh KM,Schlaak JF,Buhl R
193 πŸ“š
Oxidative damage in the central nervous system: protection by melatonin.
Progress in neurobiology (Prog Neurobiol ) Vol: 56 Issue: 3 Pages: 359-84 Pub: 1998 Oct ePub: Authors Reiter RJ
194 πŸ“š
Partners in defense, vitamin E and vitamin C.
Canadian journal of physiology and pharmacology (Can J Physiol Pharmacol ) Vol: 71 Issue: 9 Pages: 725-31 Pub: 1993 Sep ePub: Authors Chan AC
195 πŸ“š
Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease.
Archives of neurology (Arch Neurol ) Vol: 65 Issue: 10 Pages: 1348-52 Pub: 2008 Oct ePub: Authors Evatt ML,Delong MR,Khazai N,Rosen A,Triche S,Tangpricha V
196 πŸ“š
Probiotics synergized with conventional regimen in managing Parkinson's disease.
NPJ Parkinson's disease (NPJ Parkinsons Dis ) Vol: 8 Issue: 1 Pages: 62 Pub: 2022 May 24 ePub: 2022 May 24 Authors Sun H,Zhao F,Liu Y,Ma T,Jin H,Quan K,Leng B,Zhao J,Yuan X,Li Z,Li F,Kwok LY,Zhang S,Sun Z,Zhang J,Zhang H
197 πŸ“š
Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid.
Neuropharmacology (Neuropharmacology ) Vol: 24 Issue: 12 Pages: 1257-9 Pub: 1985 Dec ePub: Authors Sershen H,Reith ME,Hashim A,Lajtha A
198 πŸ“š
Protective effect of lycopene on oxidative stress and cognitive decline in rotenone induced model of Parkinson's disease.
Neurochemical research (Neurochem Res ) Vol: 36 Issue: 8 Pages: 1435-43 Pub: 2011 Aug ePub: 2011 Apr 12 Authors Kaur H,Chauhan S,Sandhir R
199 πŸ“š
Protective effect of melatonin in a chronic experimental model of Parkinson's disease.
Brain research (Brain Res ) Vol: 943 Issue: 2 Pages: 163-73 Pub: 2002 Jul 12 ePub: Authors AntolΓ­n I,Mayo JC,Sainz RM,del BrΓ­o Mde L,Herrera F,MartΓ­n V,RodrΓ­guez C
200 πŸ“š
Protective Effects of AGE and Its Components on Neuroinflammation and Neurodegeneration.
Neuromolecular medicine (Neuromolecular Med ) Vol: 18 Issue: 3 Pages: 474-82 Pub: 2016 Sep ePub: 2016 Jun 4 Authors Qu Z,Mossine VV,Cui J,Sun GY,Gu Z
201 πŸ“š
Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
Archives of neurology (Arch Neurol ) Vol: 64 Issue: 7 Pages: 938-44 Pub: 2007 Jul ePub: 2007 May 14 Authors Storch A,Jost WH,Vieregge P,Spiegel J,Greulich W,Durner J,MΓΌller T,Kupsch A,Henningsen H,Oertel WH,Fuchs G,Kuhn W,Niklowitz P,Koch R,Herting B,Reichmann H,German Coenzyme Q(10) Study Group
202 πŸ“š
Role of Dietary Supplements in the Management of Parkinson's Disease.
Biomolecules (Biomolecules ) Vol: 9 Issue: 7 Pages: Pub: 2019 Jul 10 ePub: 2019 Jul 10 Authors Ciulla M,Marinelli L,Cacciatore I,Stefano AD
203 πŸ“š
Serum vitamin D and the risk of Parkinson disease.
Archives of neurology (Arch Neurol ) Vol: 67 Issue: 7 Pages: 808-11 Pub: 2010 Jul ePub: Authors Knekt P,Kilkkinen A,Rissanen H,Marniemi J,SÀÀksjÀrvi K,Heliâvaara M
204 πŸ“š
Supplementation of probiotic Bifidobacterium breve Bif11 reverses neurobehavioural deficits, inflammatory changes and oxidative stress in Parkinson's disease model.
Neurochemistry international (Neurochem Int ) Vol: 174 Issue: Pages: 105691 Pub: 2024 Mar ePub: 2024 Feb 2 Authors Valvaikar S,Vaidya B,Sharma S,Bishnoi M,Kondepudi KK,Sharma SS
205 πŸ“š
Supplementation with Bifidobacterium animalis subsp. lactis MH-022 for remission of motor impairments in a 6-OHDA-induced Parkinson's disease rat model by reducing inflammation, reshaping the gut microbiome, and fostering specific microbial taxa.
Food & function (Food Funct ) Vol: 15 Issue: 18 Pages: 9368-9389 Pub: 2024 Sep 16 ePub: 2024 Sep 16 Authors Tsao SP,Yeh TH,Lin YT,Pan CH,Lee YK,Wu CH,Huang HY
206 πŸ“š
Synthesis and Biological Evaluation of Novel Selenyl and Sulfur-l-Dopa Derivatives as Potential Anti-Parkinson's Disease Agents.
Biomolecules (Biomolecules ) Vol: 9 Issue: 6 Pages: Pub: 2019 Jun 18 ePub: 2019 Jun 18 Authors Di Stefano A,Marinelli L,Eusepi P,Ciulla M,Fulle S,Di Filippo ES,Magliulo L,Di Biase G,Cacciatore I
207 πŸ“š
The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled trial.
Neurochemistry international (Neurochem Int ) Vol: 108 Issue: Pages: 183-189 Pub: 2017 Sep ePub: 2017 Mar 22 Authors Taghizadeh M,Tamtaji OR,Dadgostar E,Daneshvar Kakhaki R,Bahmani F,Abolhassani J,Aarabi MH,Kouchaki E,Memarzadeh MR,Asemi Z
208 πŸ“š
The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (Neurol Sci ) Vol: 38 Issue: 2 Pages: 215-224 Pub: 2017 Feb ePub: 2016 Nov 9 Authors Zhu ZG,Sun MX,Zhang WL,Wang WW,Jin YM,Xie CL
209 πŸ“š
The singlet oxygen and carotenoid interaction.
Journal of photochemistry and photobiology. B, Biology (J Photochem Photobiol B ) Vol: 11 Issue: 1 Pages: 41-7 Pub: 1991 Oct ePub: Authors Conn PF,Schalch W,Truscott TG
210 πŸ“š
Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases.
Medical hypotheses (Med Hypotheses ) Vol: 56 Issue: 4 Pages: 472-7 Pub: 2001 Apr ePub: Authors Banaclocha MM
211 πŸ“š
Therapeutic role of coenzyme Q(10) in Parkinson's disease.
Pharmacology & therapeutics (Pharmacol Ther ) Vol: 107 Issue: 1 Pages: 120-30 Pub: 2005 Jul ePub: 2005 Apr 21 Authors Shults CW
212 πŸ“š
Thymoquinone as a Potential Neuroprotector in Acute and Chronic Forms of Cerebral Pathology.
Biochemistry. Biokhimiia (Biochemistry (Mosc) ) Vol: 85 Issue: 2 Pages: 167-176 Pub: 2020 Feb ePub: Authors Isaev NK,Chetverikov NS,Stelmashook EV,Genrikhs EE,Khaspekov LG,Illarioshkin SN
213 πŸ“š
Use of probiotics for the treatment of constipation in Parkinson`s disease patients.
Minerva gastroenterologica e dietologica (Minerva Gastroenterol Dietol ) Vol: 57 Issue: 2 Pages: 117-21 Pub: 2011 Jun ePub: Authors Cassani E,Privitera G,Pezzoli G,Pusani C,Madio C,Iorio L,Barichella M
214 πŸ“š
Vinpocetine and Lactobacillus Attenuated Rotenone-Induced Parkinson's Disease and Restored Dopamine Synthesis in Rats through Modulation of Oxidative Stress, Neuroinflammation, and Lewy Bodies Inclusion.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology (J Neuroimmune Pharmacol ) Vol: 20 Issue: 1 Pages: 22 Pub: 2025 Feb 15 ePub: 2025 Feb 15 Authors Hassan HM,Abou-Hany HO,Shata A,Hellal D,El-Baz AM,ElSaid ZH,Haleem AA,Morsy NE,Abozied RM,Elbrolosy BM,Negm S,El-Kott AF,AlShehri MA,Khasawneh MA,Saifeldeen ER,Mahfouz MM
215 πŸ“š
Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: implications for Lewy body diseases.
Neurobiology of disease (Neurobiol Dis ) Vol: 25 Issue: 2 Pages: 446-54 Pub: 2007 Feb ePub: 2006 Dec 12 Authors Ono K,Yamada M
216 πŸ“š
Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
Brain research (Brain Res ) Vol: 904 Issue: 1 Pages: 67-75 Pub: 2001 Jun 15 ePub: Authors Wang JY,Wu JN,Cherng TL,Hoffer BJ,Chen HH,Borlongan CV,Wang Y
217 πŸ“š
Withania somnifera (L.) Dunal (Ashwagandha): A comprehensive review on ethnopharmacology, pharmacotherapeutics, biomedicinal and toxicological aspects.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 143 Issue: Pages: 112175 Pub: 2021 Nov ePub: 2021 Sep 27 Authors Paul S,Chakraborty S,Anand U,Dey S,Nandy S,Ghorai M,Saha SC,Patil MT,Kandimalla R,ProckΓ³w J,Dey A

Quick Reference

The following items have been cited in the above studies

IDStudiesNameAKA
3149 5   1,2-dithiolane-3-pentanoic acid {a-Lipoic acid (ALA)} Alpha-Lipoic acid,Thioctic acid,Lipoic acid.High in organ meats
2371 3   2-Methyl-5-(1-methylethyl)phenol {Carvacrol} Found in Oregano, Thyme, Pepperwort,Wild Bergamot, Lamiaceae family
3201 1   3,5,7-trihydroxy-2-(4-hydroxyphenyl)chromen-4-one {kaempferol} Kempferol,Rhamnolutein,Rhamnolutin,Robigenin,Pelargidenolon,Populnetin,Trifolitin,Swartziol
1933 2   Akkermansia muciniphila {Pendulum Probiotic}
7 1   allium sativum {garlic} garlic,allium sativum,allium
316 2   alpha-linolenic acid {Omega-3} ALA. Plant based, Flaxseed, otherwise see Fish oil NOT a-Lipoic acid (also ALA)
1912 7   alpha-tocopherol {Vitamin E} including four tocopherols (alpha, beta, gamma, delta) and four tocotrienols (alpha, beta, gamma, delta)
2952 1   Arctium lappa {Burdock Root} Lappa,Beggar's buttons,Thorny burr,Happy major,Fox's clote,Cockle buttons,Love leaves,Philanthropium,Personata,Clot-bur
1864 4   ascorbic acid {Vitamin C}
216 1   aspergillus oryzae {koji} Koji mould,Japanese koji mold,Rice koji
32 2   bacillus subtilis {B.Subtilis } Hay bacillus, grass bacillus,Vibrio subtilis
1648 1   benserazide hydrochloride non-drug
3008 1   Bifidobacterium animalis {B. animalis} Bifidobacterium longum subsp. animalis biotype a,Bifidobacterium animalis subsp. lactis
46 1   Bifidobacterium animalis subsp. lactis {B. Lactis} Includes BB-12, DN-173 010 ,Bifidobacterium Regularis,Bifidus Regularis
1943 3   Bifidobacterium breve {B. breve}
49 2   bifidobacterium infantis {B. infantis}
1778 1   brown algae
2980 6   Coenzyme Q10 {CoQ 10} Ubiquinone,Ubidecarenone,Vitamin Q10,Mitoquinone
1824 8   Diferuloylmethane {Curcumin} Extract from Turmeric (which contains other chemicals)
3154 1   fucoidan {Brown Algae Extract} Commercially extracted from Fucus vesiculosus (wracks), Cladosiphon okamuranus, Laminaria japonica (kombu, sugar kelp), and Undaria pinnatifida (wakame).
176 1   green tea
4521 1   Hericium erinaceus {Lion's Mane Mushroom } Yamabushitake (Japanese), Bearded Tooth Fungus, Monkey's Head Mushroom, Hedgehog Mushroom, Old Man's Beard,Bearded Hedgehog
215 1   ketogenic diet
234 1   Lacticaseibacillus casei {L. casei} Streptobacterium casei,Lactobacillus casei
235 1   Lacticaseibacillus paracasei shirota {Yakult} LcS
230 1   lactobacillus acidophilus {L. acidophilus} Bacillus acidophilus
243 2   Lactobacillus plantarum {L. plantarum} lactobacillus plantarum, Lactobacillus arabinosus
1175 1   levodopa,(prescription) (antiparkin, apodespan pr, apo-levocarb, aurimel, bendopa, bendopar, benspar, bidopal, bidopar, carbidopa + levodopa teva, carbidopa + levodopa winthrop, carbidopa and levodopa actavis, carbidopa and levodopa sun, carbidopa and levodopa teva, carbidopa lévodopa teva, carbidopa lévodopa teva lp, carbidopa/levodopa bristol, carbidopa/levodopa remedica, carbidopa/levodopa sandoz cr, carbilev, carcopa, cardopar, carlevod, cenparkin, cloisone, co-careldopa, co-dopa, credanil, cronomet, darpott, d-dopa, domtab, dopa merz, dopacol, dopadura b, dopadura c, dopamar, dopamar mite, dopasol, dopaston, dopicar, duodopa, duopa, ec doparl, enpalevo, flexilev, grifoparkin, half sinemet, hardal, isicom, isicom retard, kardopal, kardopal mite, kinson, lebocar, lecado, lecardop, lecardopa, lecarge, ledocar, leparson, leprinton, levacin, levazide, levoben, levobens-teva, levobeta c, levobeta c retard, levo-c al, levocar, levocar cr, levocar retard, levocarb - 1 a pharma, levocarb, levocarb ret - 1 a pharma, levocarb-gry, levocarb-teva, levocomp, levocomp retard, levodopa - beida pharm, levodopa / benserazide teva, levodopa + benserazide teva italia, levodopa + carbidopa hexal, levodopa + carbidopa mylan, levodopa benserazid beta, lévodopa bensérazide teva, levodopa c. comp. abz, levodopa comp. b stada, levodopa comp.-ct, levodopa fu seng, levodopa plus benserazid, levodopa/benseraside teva, levodopa/benserazid ratiopharm, levodopa/benserazid-ct, levodopa/benserazide central, levodopa/benserazide pch, levodopa/benserazide teva, levodopa/benserazid-neuraxpharm, levodopa/benserazid-ratiopharm, levodopa/carbidopa abz, levodopa/carbidopa accord, lévodopa/carbidopa accord lp, levodopa/carbidopa mylan, levodopa/carbidopa pch, levodopa/carbidopa ratiopharm, levodopa/carbidopa ratiopharm retard, levodopa/carbidopa retard cf, levodopa/carbidopa retard hexal, levodopa/carbidopa retard pch, levodopa/carbidopa retard stada, levodopa/carbidopa sandoz retard, levodopa/carbidopa stada, levodopa/carbidopa teva, levodopa/carbidopa/entacapone sandoz, levodopa/carbidopa-ct, levodopa/carbidopa-ratiopharm, levodopa-benserazid teva, levodopa-benserazide, levodopa-ratiopharm comp., levodop-neuraxpharm, levodop-neuraxpharm retard, levofamil, levokom, levomed, levomet, levopa, levopar, levopar plus, madopar, madopar cr, madopar cr roche, madopar depot, madopar dispersible, madopar dr, madopar hbs, madopar lt, madopar quick, madopar rapid, madopar retard, madopar roche, madopar roche hbs, madopark, madopark depot, madopark mite, madozide, majormet, melitase, menesit, menkart, modopar, modopar lp, nacom, nakom, nakom mite, neodopasol, neodopaston, parcopa, pardopa, pardoz, parkidopa, parkimet, parkinel, parkiston, pms-levocarb cr, prikap, prolopa, prolopa hbs, rekoveren, restex, rytary, saniter compuesto, sindopa, sinemet, sinemet cr, sinemet depot, sinemet depot mite, sinemet lp, sinemet plus, sinemet plus retard, sinemet retard, sinepar, sulconar, symblyopia, syndopa, syndopa cr, teva carbi-levo, teva-levodopa carbidopa, tidomet, tidomet forte, vopar, xi lai mei, zamdopa)
245 1   Limosilactobacillus reuteri {L. Reuteri} Lactobacillus fermentum subsp. reuteri
2937 5   Lycopene {Glucosamine (GS)} All-trans-lycopene,?,?-carotene, Found in (Tomatoes,Watermelon,Pink grapefruit,Guava,Papaya,Red carrots)
4541 4   N-(aminoiminomethyl)-N methyl glycine {Creatine} Red meat (beef, pork),Poultry (chicken, turkey),Fish (tuna, salmon, herring)
282 5   N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide {Melatonin} a hormone primarily produced by the pineal gland
1055 7   N-Acetyl Cysteine {NAC} (abinac, acc, acc acute, acc akut hustenlöser, acc akut junior hustenlöser, acc baby, acc extra, acc hexal, acc hexal long, acc hot, acc junior, acc kid, acc kinder, acc long, acc mini, acc neo, acc sandoz, acc z hustenlöser, acc200, acemuc, acemuk, acet, acetadote, acetein, acetilcisteina, acetilcisteina angenerico, acetilcisteina bexal, acetilcisteina bluval, acetilcisteina cinfa, acetilcisteina coop, acetilcisteina davur, acetilcisteina doc, acetilcisteina doc generici, acetilcisteina eg, acetilcisteina farmasierra, acetilcisteina hexal, acetilcisteina hexal a/s, acetilcisteina hexal ag, acetilcisteina kern pharma, acetilcisteinã laropharm, acetilcisteinã lph, acetilcisteina mylan, acetilcisteina mylan generics italia, acetilcisteina normon, acetilcisteina pensa, acetilcisteina ratiopharm, acetilcisteina sandoz, acetilcisteina tarbis, acetilcisteina tolife, acetilcisteina ur, acetilcisztein-wagner, acetin, acetyl, acetylcistein sedico, acetylcystein actavis, acetylcystein adeka, acetylcystein alternova, acetylcystein helvepharm, acetylcystein hexal, acetylcystein meda, acetylcystein mylan, acetylcystein nycomed, acetylcystein sad, acetylcystein sandoz, acetylcystein stada, acetylcystein teva, acetylcysteine, acetylcysteine 20%, acetylcysteine actavis, acetylcysteïne alpex, acetylcysteine alveda, acetylcysteine apotex, acétylcystéine arrow, acetylcysteine aurum, acétylcystéine biogaran, acetylcysteine biopolus, acetylcysteïne birchwood, acetylcysteine cf, acetylcysteine eg, acétylcystéine eg, acetylcysteïne htp, acetylcysteine imphos, acetylcysteine max health, acetylcysteine mdq, acetylcysteine mylan, acetylcysteïne mylan, acétylcystéine mylan, acetylcysteine pch, acetylcysteine pharos, acétylcystéine ratiopharm, acetylcysteine rxt, acetylcysteïne sam, acetylcysteine samenwerkende apothekers, acetylcysteine sandoz, acetylcysteïne sandoz, acétylcystéine sandoz, acetylcysteine sanias, acetylcysteine teva, acétylcystéine teva, acetyleine granules, acetyst kinder, act, actein, acypront, aeromuc, aflux, aires, alles-600, altersol, amavita acetylcystein, amuco 200, asibrox, asist, asixintai, aspirin effect, astein, bexin hustenlöser, bisolbruis, brimodin, bromuc, bronchocil, bronchostad, broncoflem, broncohexal, broncolium, bronkyl, bronpax, brunac, cetilan, chitan, chricetyl, cinetix, codotussyl, coop vitality acetylcystein, cystaline, cystenon, cystin, da hoestbruistabletten acetylcysteïne, dbl acetylcysteine, detoxnac, dorbigot, drenaflen, dynamucil, ecomucyl, encc, encore, equimucil, equimucin, equsil, esomez, euronac 5%, evanac, exflem, exomuc, extal, flemex-ac, flemex-ac od, flucistein, flucisteín, flucistein lafrancol, fluibroncol, fluidasa, fluimed, fluimucil, fluimucil 10%, fluimucil 2%, fluimucil 2% pediatric, fluimucil 20%, fluimucil 20% antidot, fluimucil 4%, fluimucil a, fluimucil acetylcysteine 2% expectorant, fluimucil acetylcysteine 2% expectorant enfants, fluimucil acetylcysteine expectorant, fluimucil antidot, fluimucil antidot 20%, fluimucil complex, fluimucil erkältungshusten, fluimucil forte, fluimucil grippe day night, fluimucil hustenlöser, fluimucil junior, fluimucil kinder, fluimucil long, fluimucil mucolitico, fluimucil n, fluimukan, fluimukan junior, fluimukan plus, fluimukan za djecu, fluixx, flumivit, flumixol, flutafin, fluvisan, fucocil, fumucil, génac 5%, glotamuc, hepaguard, hidonac, hoestbruistabletten acetylcysteïne, husten acc hexal, idyl acetylcysteïne, ilube, ilube 5%, iniston mucus, kantrenol, kofimucil mucolitico, kotan, kruidvat acetylcysteïne, l-cimexyl, leidapharm acetylcysteine, lysomucil, lysox, lysox junior, madame pearl`s mucolytic, mae acetylcysteine, mekomucosol, menaxol, menaxol forte, mentopin, moktin, mucatak, mucil, mucinac, muclear, mucoaliv, mucobene, mucocar, mucocetil, mucocil, mucocure, mucocure pediatrik, mucofial, mucofluid, mucofrin, mucolator, mucolator pediatrik, mucolator plus, mucolid sf, mucolitico, mucolyse, mucolysin, mucolysin skovbær, mucomax, muco-mepha, mucomucil, mucomyst, mucomystendo, muconex, muconex pediatrik, mucopd, mucoplus, mucorpin, mucosil acc, mucosof, mucosten, mucostop, muco-t, mucotab, mucotic, mucovim, mucovit, muco-x, mucoxan, muculator, mucuspen, mucylin, mukolatin, musol, mutamso, muxatil, muxystine, mysoven, n.a.c., nac, nac - 1 a pharma, nac akut - 1 a pharma, nac al, nac long, nac-ct, n-ace, nacecis, nacel, n-acetilcisteina germed, n-acetilcisteína la santé, n-acetilcisteína mk, n-acetylcysteine alpex, nac-ratiopharm, nac-ratiopharm akut hustenlöser, nac-stada, nactop, nytex, omegapharm acetylcysteine, oxxa, paradote, parvolex, pectocil, pms-imecystine, pulmosal, ratiomucol, reolin, restofit, rinofluimucil, rinoflumil, sezumine, simucil, simucin, siran, siran forte, sistenol, sistin, solmucaïne, solmucalm, solmucalm für kinder, solmucol, solmucol 10%, solmucol für kinder, solmucol mucolitico, stenac, sutun, tirocular, toflux, trebon, tussamag nac, tussicom, vedilan, vensy, vetemucil, vicks acetylcysteine, vlenolys, xpecto plus, yi wei shi) ,N-Acetylcysteine, Acetylcysteine
2939 1   Nattokinase {Natto} Fermented soybean product made with Bacillus subtilis var. natto
307 6   nicotinic acid {Vitamin B-3} B3,niacin, nicotinamide, nicotinamide riboside
1719 4   Nigella sativa {black cumin} black seed, black caraway, kalonji,fennel flower
1928 1   Solanum tuberosum {Potatoes} Spud,Tater,Earth apple
2950 4   ß-Carotene {Carrots} Betacarotenum,Provitamin A,Trans-beta-carotene
1822 1   Tobacco consumption {Smoking}
1243 1   vinpocetine,(prescription) (angiovan, avintol, bai rui de, bang chuan nai xin, bo jian, bravinton, camiton, cav acapi, cavalpha, cavestine, cavinil, cavinton, cavinton forte, caviton, cerbrocil, cereton, cerevas, cerivin, chang gui qing, circufit, ding na, duolikang, hua mai tong, jie li shu, li nuo sheng, ning xu xin, qing he, run he er, run tan, shu lin, tailiping, tong ming, ultra-vinca, veinpo, vicebrol, vicebrol forte, vicetin, vicog, vimpocetin vim spectrum, vincet, vinctine, vinpocetin covex, vinpocetin laropharm, vinpocetina covex, vinpocetina kern, vinpocetine, vinpocetine covex, vinpocetine espefa, vinpocetine espefa forte, vinpocetine gedeon, vinpocetine hasco, vinpocetine kern, vinpocetine-aconitum, vinpocetine-akri, vinpocetine-darnitsa, vinpocetine-rivo, vinpohasco, vinporal, vinpotaxer, vinpoton, vinpoton forte, vinsetine, vinton, vipocem, vipodendril, wei li ming, yi qi xian, yuan tuo, zui xing)
424 5   vitamin d cholecalciferol,Vitamin D3, activated 7-dehydrocholesterol
23 3   Withania somnifera {Ashwagandha} Indian Ginseng,Indian Winter Cherry
163 3   Zingiber officinale Roscoe {ginger} Jiang,Adrak
430 2   β-lactoglobulin {Whey} Liquid byproduct of cheese or casein manufacture, Lactalbumin, Whey protein / isolates / hydrolysates

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]